INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
INO fundamentals
Inovio Pharmaceuticals (INO) released its earnings on Mar 12, 2026: revenue was 0 (YoY -100.00%), met estimates; EPS was -0.26 (YoY +60.00%), beat estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.26
+60.00%
Report date
Mar 12, 2026
INO Earnings Call Summary for Q4,2025
- FDA Milestone Progress: INO-3107 BLA under accelerated review with PDUFA date of October 30, 2026; awaiting FDA meeting to address eligibility concerns.
- Clinical Differentiation: 72% of patients achieve 50%-100% surgery reduction vs. 72% of PALSEFIO complete responders requiring intra-treatment surgeries.
- Financial Sustainability: Extended cash runway to Q4 2026 with $22M Q1 net burn; $88.5M cash on hand.
- Commercial Readiness: 80% of launch infrastructure built; RRP Foundation endorses INO-3107 as first-line therapy.
- Pipeline Focus: INO-3107 prioritized; partnerships to advance DPROT and dMAb programs.
EPS
Revenue
Revenue & Expenses
Key Indicators
Inovio Pharmaceuticals (INO) key financial stats and ratios, covering profitability, financial health, and leverage.
Inovio Pharmaceuticals (INO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Inovio Pharmaceuticals (INO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Inovio Pharmaceuticals (INO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Inovio Pharmaceuticals (INO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Inovio Pharmaceuticals (INO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Inovio Pharmaceuticals's management provide for the next earnings period?What does Inovio Pharmaceuticals do and what are its main business segments?What is the market's earnings forecast for Inovio Pharmaceuticals next quarter?What is Inovio Pharmaceuticals's gross profit margin?What is the revenue and EPS growth rate for Inovio Pharmaceuticals year over year?What were the key takeaways from Inovio Pharmaceuticals's earnings call?Did Inovio Pharmaceuticals beat or miss consensus estimates last quarter?What factors drove the changes in Inovio Pharmaceuticals's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
